PGHH · Consumer Defensive · Household & Personal Products
Composite scorecard: 50/100 — Quality 95 · Valuation 49 · Growth 19 · Momentum 0
| Share price | ₹8,092.00 |
| Market cap | ₹36,846 Cr |
| P/E ratio | 51.5 |
| P/B ratio | 39.6 |
| ROCE | 135.4% |
| Dividend yield | 2.07% |
| Book value | ₹286.89 |
| Year | Sales | Net profit | OPM |
|---|---|---|---|
| 2026 | ₹4,282 Cr | ₹856 Cr | 26.5% |
| 2024 | ₹4,192 Cr | ₹675 Cr | 22.6% |
| 2023 | ₹3,905 Cr | ₹678 Cr | 21.1% |
| 2022 | ₹3,792 Cr | ₹576 Cr | 20.9% |
| 2021 | ₹3,570 Cr | ₹652 Cr | 24.0% |
Procter & Gamble Hygiene and Health Care Limited manufactures and sells branded packaged fast-moving consumer goods in the feminine care and healthcare businesses in India and internationally. It operates through Health care Products and Hygiene Products segments. The company offers health care products, including ointments and creams, cough drops, and tablets; and hygiene products, such as feminine hygiene and other skin care hygiene products, as well as feminine care pads. It also provides baby care products comprising nappies, pants, and baby wipes; grooming products; laundry products; hair